Early Results (at 6 Months) with Intermittent Clarithromycin-Including Regimens for Lung Disease Due to Mycobacterium avium Complex
Open Access
- 1 February 2000
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 30 (2), 288-292
- https://doi.org/10.1086/313644
Abstract
We initiated a prospective noncomparative trial of treatment for lung disease due to Mycobacterium avium complex (MAC) in human immunodeficiency viruKeywords
This publication has 15 references indexed in Scilit:
- A Randomized, Placebo‐Controlled Study of Rifabutin Added to a Regimen of Clarithromycin and Ethambutol for Treatment of Disseminated Infection with Mycobacterium avium ComplexClinical Infectious Diseases, 1999
- Randomized, Open‐Label Trial of Azithromycin Plus Ethambutol vs. Clarithromycin Plus Ethambutol as Therapy forMycobacterium aviumComplex Bacteremia in Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 1998
- Varying Dosages of Rifabutin Affect White Blood Cell and Platelet Counts in Human Immunodeficiency Virus-Negative Patients Who Are Receiving Multidrug Regimens for Pulmonary Mycobacterium avium Complex DiseaseClinical Infectious Diseases, 1996
- Azithromycin Activity Against Mycobacterium avium Complex Lung Disease in Patients Who Were Not Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- A Comparison of Two Regimens for the Treatment ofMycobacterium aviumComplex Bacteremia in AIDS: Rifabutin, Ethambutol, and Clarithromycin versus Rifampin, Ethambutol, Clofazimine, and CiprofloxacinNew England Journal of Medicine, 1996
- Prophylaxis against DisseminatedMycobacterium aviumComplex with Weekly Azithromycin, Daily Rifabutin, or BothNew England Journal of Medicine, 1996
- Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.American Journal of Respiratory and Critical Care Medicine, 1996
- Adverse Events Associated with High-Dose Rifabutin in Macrolide-Containing Regimens for the Treatment of Mycobacterium avium Complex Lung DiseaseClinical Infectious Diseases, 1995
- Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease.American Journal of Respiratory and Critical Care Medicine, 1994
- Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC systemAntimicrobial Agents and Chemotherapy, 1992